Volt - California, MD - VOLT are currently partnered with a client in San Fransico Bay Area, in United States, who are looking to make a real difference in the in the Cell Therapy Field.. Currently, our client is establishing a new manufacturing technology that has huge potential for both autologous & allogenic cell therapies. This is a unique opportunity where you can implement the process development strategy and department from scratch. This is a chance for you to build and develop your own team providing strong leadership to team members, training programs and business plan for your team. Some of your responsibilities in this role will be: ● Must be the subject matter expert with regard to any cell therapy manufacturing questions. ● You will be responsible for selection and commissioning of lab equipment, lab build out, experiments,performing experiments, interpreting data, and presenting results for both internal/external meetings e.g conferences, stakeholder meetings etc. ● Acting as the primary point of contact for setting up and establishment of cell therapy manufacturing processes including the following process steps: whole blood processing, apheresis processing, cell isolation, T-cell activation, gene transfer using large volume transfection and/or viral vectors, cell expansion. ● Performing cell therapy manufacturing related tasks while wearing clean room attire in an aseptic GMP manner. You will need the following expertise: Relevant PhD degree in Biological sciences Experience with different modalities of genetically modified cell therapies (e.g. CAR-T, TCR, HSCs, CD34). Experience with both autologous and allogeneic cell therapy manufacturing workflows. Can either preclinical or clinical cell therapy manufacturing. Experience in building process development teams Good working knowledge of FDA GMP If you want to know more about this opportunity do not hesitate to get in contact; Apply now... - Permanent - Full-time
source http://jobviewtrack.com/en-in/job-4c49416944160a0d531b5243381301040053076a2d1a584e5e5942166d3e551b43061b126f5657134c5a/bc5bbf1a2e30fdb927e098848364af25.html?affid=f584d43114bf1954a48e3ec6be21b6ec
Subscribe to:
Post Comments (Atom)
-
NSE IFSC-SGX Connect may be fully operational by June https://ift.tt/XC89Iks this connectivity, global investors who are clients of SGX will...
-
Tough challenges await Rishi Sunak: Tory strategists https://ift.tt/ibXqIld has successfully eaten into the opposition poll lead - Keir Star...
-
Cryptocurrency, or "crypto" or "tokens", is all the rage right now. People are buying and using cryptos for varied purpo...
No comments:
Post a Comment